fibroblasts

NEEDHAM, Massachusetts, August 11, 2026 Mighty Therapeutics, a commercial-stage biotechnology company focused on therapies targeting mitochondrial dysfunction, and a...

HOUSTON, Texas, August 11, 2026 FibroBiologics, Inc. announced that the United States Patent and Trademark Office (USPTO) has issued...

HOUSTON | January 6, 2026 — FibroBiologics, Inc. announced that its Founder and Chief Executive Officer will present at...